Mediantechn (ALMDT) - Total Assets
Based on the latest financial reports, Mediantechn (ALMDT) holds total assets worth €35.87 Million EUR (≈ $41.94 Million USD) as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Mediantechn - Total Assets Trend (2008–2025)
This chart illustrates how Mediantechn's total assets have evolved over time, based on quarterly financial data. Also see Mediantechn (ALMDT) market capitalisation for the company's overall valuation and market capitalisation.
Mediantechn - Asset Composition Analysis
Current Asset Composition (December 2025)
Mediantechn's total assets of €35.87 Million consist of 87.4% current assets and 12.6% non-current assets. Review Mediantechn (ALMDT) financial obligations to assess the company's total debt and financial obligations.
| Asset Category | Amount (EUR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 50.9% |
| Accounts Receivable | €8.88 Million | 24.8% |
| Inventory | €80.00K | 0.2% |
| Property, Plant & Equipment | €0.00 | 0.0% |
| Intangible Assets | €1.77 Million | 4.9% |
| Goodwill | €0.00 | 0.0% |
Asset Composition Trend (2008–2025)
This chart illustrates how Mediantechn's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See ALMDT share price today for real-time trading data and today's change.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Mediantechn's current assets represent 87.4% of total assets in 2025, a decrease from 92.7% in 2008.
- Cash Position: Cash and equivalents constituted 50.9% of total assets in 2025, up from 7.5% in 2008.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 4.0% of total assets, an increase from 2.0% in 2008.
- Asset Diversification: The largest asset category is accounts receivable at 24.8% of total assets.
Mediantechn Competitors by Total Assets
Key competitors of Mediantechn based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223
|
China | CN¥16.89 Billion |
|
Shandong Weigao Orthopaedic Device Co. Ltd. A
SHG:688161
|
China | CN¥5.19 Billion |
|
Jafron Biomedical Co Ltd
SHE:300529
|
China | CN¥5.20 Billion |
|
Ningbo David Medical Device Co Ltd
SHE:300314
|
China | CN¥1.47 Billion |
|
Beijing Succeeder Technology Inc
SHG:688338
|
China | CN¥1.78 Billion |
|
Dirui Industrial Co Ltd
SHE:300396
|
China | CN¥2.57 Billion |
|
Profound Medical Corp
TO:PRN
|
Canada | CA$62.28 Million |
|
Affluent Medical SAS
PA:AFME
|
France | €59.84 Million |
Mediantechn - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.67 | 0.47 | 1.15 |
| Quick Ratio | 0.67 | 0.46 | 1.15 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | €-15.41 Million | €-23.58 Million | €3.08 Million |
Mediantechn - Advanced Valuation Insights
This section examines the relationship between Mediantechn's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 252.66 |
| Latest Market Cap to Assets Ratio | 4.92 |
| Asset Growth Rate (YoY) | 47.2% |
| Total Assets | €35.87 Million |
| Market Capitalization | $176.64 Million USD |
Valuation Analysis
Premium Asset Valuation: The market values Mediantechn's assets at a significant premium (4.92x), suggesting investors see substantial growth potential or unique competitive advantages.
Rapid Asset Growth: Mediantechn's assets grew by 47.2% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Mediantechn (2008–2025)
The table below shows the annual total assets of Mediantechn from 2008 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | €35.87 Million ≈ $41.94 Million |
+47.19% |
| 2024-12-31 | €24.37 Million ≈ $28.49 Million |
-32.18% |
| 2023-12-31 | €35.94 Million ≈ $42.01 Million |
+3.40% |
| 2022-12-31 | €34.75 Million ≈ $40.63 Million |
-29.63% |
| 2021-12-31 | €49.39 Million ≈ $57.74 Million |
+95.33% |
| 2020-12-31 | €25.28 Million ≈ $29.56 Million |
+56.84% |
| 2019-12-31 | €16.12 Million ≈ $18.85 Million |
-11.17% |
| 2018-12-31 | €18.15 Million ≈ $21.22 Million |
-46.85% |
| 2017-12-31 | €34.14 Million ≈ $39.92 Million |
-26.66% |
| 2016-12-31 | €46.55 Million ≈ $54.43 Million |
+38.76% |
| 2015-12-31 | €33.55 Million ≈ $39.22 Million |
+87.74% |
| 2014-12-31 | €17.87 Million ≈ $20.89 Million |
+4178.62% |
| 2013-12-31 | €417.66K ≈ $488.29K |
-14.49% |
| 2012-12-31 | €488.41K ≈ $571.00K |
-95.34% |
| 2011-12-31 | €10.47 Million ≈ $12.24 Million |
+124.34% |
| 2010-12-31 | €4.67 Million ≈ $5.46 Million |
-7.05% |
| 2009-12-31 | €5.02 Million ≈ $5.87 Million |
-13.80% |
| 2008-12-31 | €5.83 Million ≈ $6.81 Million |
-- |
About Mediantechn
Median Technologies SA engages in providing medical imaging products and services for diagnosing and monitoring cancer patients in both routine clinical practice and clinical drug development with operations spanning in France, the United States, Canada, the United Kingdom, China, and internationally. The company offers iSee for imaging services in clinical trials; eyonis for non-invasive diagnos… Read more